Characteristics of acute congestive heart failure with normal ejection fraction and less elevated B-type natriuretic peptide
Open Access
- 24 January 2009
- journal article
- research article
- Published by Springer Nature in BMC Cardiovascular Disorders
- Vol. 9 (1) , 2
Abstract
Background: Heterogeneity in B-type natriuretic peptide (BNP) levels, especially among individuals with acute heart failure with normal left ventricular ejection fraction (HFNEF), can cause confusion in interpreting results. We investigated the characteristics of cases of acute HFNEF with only modestly elevated BNP. Methods: One hundred forty-two patients with acute or acute exacerbation of chronic HFNEF were divided into two groups by BNP level: BNP < 100 pg/ml (NB group, n = 45) and BNP ≥ 100 pg/ml (B group, n = 97). We compared clinical findings, echocardiography results, and neurohormonal factors between these two groups. Results: In the NB group, a history of open-heart surgery (OHS) was more frequent (71% vs. 22%, p < 0.0001) and hypertension was less frequent (p = 0.0005). Left atrial diameter (LAd) was higher (p = 0.0026), while interventricular septal thickness, posterior wall thickness, relative wall thickness, left ventricular mass index were lower (p = 0.0005, p = 0.0225, p = 0.0114, p = 0.0051, respectively) in the NB group. In patients with HFNEF, a history of OHS remained an independent predictor of BNP level (< 100 pg/ml) after adjustment for hypertension, age, LAd, and interventricular septal thickness (odds ratio 3.6, p = 0.0252). Conclusion: We found associations between acute HFNEF with less elevated BNP and a history of OHS. In a patient suspected of HFNEF, a history of OHS is considered diagnostic evidence of presence of diastolic heart failure when plasma levels of BNP are less elevated.Keywords
This publication has 31 references indexed in Scilit:
- B-type natriuretic peptide level in a patient with constrictive pericarditisCatheterization and Cardiovascular Interventions, 2006
- Impact of Atrial Fibrillation on the Diagnostic Performance of B-Type Natriuretic Peptide Concentration in Dyspneic PatientsJACC, 2005
- Neurohumoral Pathways in Heart Failure With Preserved Systolic FunctionProgress in Cardiovascular Diseases, 2005
- Pathophysiological Characterization of Isolated Diastolic Heart Failure in Comparison to Systolic Heart FailureJAMA, 2002
- Comparative value of Doppler echocardiography and B-type natriuretic peptide assay in the etiologic diagnosis of acute dyspneaJACC, 2002
- Rapid Measurement of B-Type Natriuretic Peptide in the Emergency Diagnosis of Heart FailureNew England Journal of Medicine, 2002
- B-type natriuretic peptide as a marker of the effects of enalapril in patients with heart failureThe American Journal of Medicine, 2002
- The potential of brain natriuretic peptide as a biomarker for New York Heart Association class during the outpatient treatment of heart failureJournal of Cardiac Failure, 2002
- B-TYPE NATRIURETIC PEPTIDE IN THE DIAGNOSIS AND MANAGEMENT OF CONGESTIVE HEART FAILURECardiology Clinics, 2001
- Atrium as a source of brain natriuretic polypeptide in patients with atrial fibrillationJournal of Cardiac Failure, 2000